• About
  • Science
  • Pipeline
  • Investors
  • Contact
English
中文 English

Press Releases

February, 2026

GD-19 and GD-20 Successfully Complete Phase I Clinical Trials

read more
May, 2023

GD BioPharma Secures RMB 50 Million in Series A Financing

read more
June, 2014

GD BioPharma Completed RMB 20 Million Angel Round Financing

read more

Presentations

February, 2026

GD-20 Phase 1 Clinical Data Update

read more

Upcoming and Recent Events

November, 2025

GD-20 Phase 1 Clinical Data Update

read more

Tianjin, China

Room 725, Building B, No. 5 Lanyuan Road, Huayuan Industrial Zone

+86-022-8371-7781

General Inquiry

guduibio@126.com

Investors

guduibio@126.com
  • About
  • Science
  • Pipeline
  • Investors
  • Contact
+86-022-8371-7781

Address: Room 725, Building B, No. 5 Lanyuan Road, Huayuan Industrial Zone

Email: guduibio@126.com

© 2026 Designed to Cure, Driven by Care